SHOP APOTHEKE EUROPE N.V. PUBLISHES AGENDA ANNUAL GENERAL MEETING OF SHAREHOLDERS 2020 (ENGLISH ONLY)

DGAP-News: SHOP APOTHEKE EUROPE N.V. / Schlagwort(e): Hauptversammlung
SHOP APOTHEKE EUROPE N.V. PUBLISHES AGENDA ANNUAL GENERAL MEETING OF
SHAREHOLDERS 2020 (ENGLISH ONLY)

19.03.2020 / 15:50
Für den Inhalt der Mitteilung ist der Emittent / Herausgeber verantwortlich.

---------------------------------------------------------------------------

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN THE USA, CANADA, AUSTRALIA
OR JAPAN.

SHOP APOTHEKE EUROPE N.V. PUBLISHES AGENDA ANNUAL GENERAL MEETING OF
SHAREHOLDERS 2020

Venlo, 19 March 2020. SHOP APOTHEKE EUROPE N.V. ("SHOP APOTHEKE EUROPE" or
the "Company") has today published the agenda for the annual general meeting
of shareholders of the Company (the "AGM"). Based on today's risk
assessment, the Company has convened the AGM and plans to hold the AGM on 30
April 2020. However, due to possible further developments with respect to
the Covid-19 outbreak, the Company will continuously assess the risk
situation, taking into account the assessments of the responsible
authorities, and may decide on any further measures in relation to the AGM.
We will keep you informed about further developments on our website.

The convocation announcement and the agenda, the accompanying explanatory
notes and other information and documentation are available on the corporate
website of the Company ( http://shop-apotheke-europe.com) under Investor
Relations / General Meeting / Annual General Meeting 2020 and via the link:

http://shop-apotheke-europe.com/en/investorrelations/hauptversammlung/

The AGM is scheduled to take place on Thursday, 30 April 2020, starting at
10:00 CEST at Bilderberg Chateau Holtmuhle, Kasteellaan 10, 5932 AG,
Tegelen, The Netherlands.

SHOP APOTHEKE EUROPE gives top priority to the health of its employees,
shareholders and other stakeholders when holding the AGM. Normally, the
Company's managing board would of course be pleased that you attend the AGM
in person. However, today, the Company urges all its shareholders to
carefully consider whether they wish to attend the AGM in person this year
in view of possible health risks relating to the Covid-19 outbreak.

Against this background, the Company strongly encourages its shareholders to
take part in the AGM this year by way of proxy voting and not to attend the
AGM in person. This way, the physical meeting can take place with only a
limited number of core attendees and health risks for those attendees can be
limited as much as possible.

Shareholders who are entitled to attend the AGM, and who choose to be
represented and to cast their votes by proxy, can follow the meeting via
webcast on 30 April 2020. In addition, those shareholders can ask questions
in advance of the AGM. Please refer to Section 3 (General Information) of
the convocation announcement for further details regarding the proxy voting
option, how to follow the meeting via the webcast and how to ask questions
in advance of the AGM.

SHOP APOTHEKE EUROPE strives to take the best measures possible in view of
the Covid-19 outbreak, while limiting interruption to its business
(including the AGM) as much as possible. The option of proxy voting is a
good alternative to attendance in person, and enables all of our
shareholders to cast their votes on the AGM voting items.

Furthermore, shareholders who wish to participate in the AGM are advised to
check the AGM page on the Company's corporate website regularly to stay
informed about the latest developments.

For further information please contact us at:

Investor Relations:
Rens Jan Kramer
Telephone: +31 77 850 6672
Email: rensjan.kramer@shop-apotheke.com

Trade and public media:
Sven Schirmer
Mobile: +49 152 28 50 63 61
Email: presse@shop-apotheke.com

Financial media:
Thomas Schnorrenberg
Mobile: +49 151 46 53 13 17
Email: presse@shop-apotheke.com

---------------------------------------------------------------------------

19.03.2020 Veröffentlichung einer Corporate News/Finanznachricht,
übermittelt durch DGAP - ein Service der EQS Group AG.
Für den Inhalt der Mitteilung ist der Emittent / Herausgeber verantwortlich.

Die DGAP Distributionsservices umfassen gesetzliche Meldepflichten,
Corporate News/Finanznachrichten und Pressemitteilungen.
Medienarchiv unter http://www.dgap.de

---------------------------------------------------------------------------

   Sprache:        Deutsch
   Unternehmen:    SHOP APOTHEKE EUROPE N.V.
                   Dirk Hartogweg 14
                   5928 LV Venlo
                   Niederlande
   Telefon:        0800 - 200 800 300
   Fax:            0800 - 90 70 90 20
   E-Mail:         carmen.herkenrath@shop-apotheke.com
   Internet:       www.shop-apotheke-europe.com
   ISIN:           NL0012044747, DE000A19Y072
   WKN:            A2AR94, A19Y07
   Indizes:        SDAX
   Börsen:         Regulierter Markt in Frankfurt (Prime Standard);
                   Freiverkehr in Berlin, Düsseldorf, Hamburg, Hannover,
                   München, Stuttgart, Tradegate Exchange
   EQS News ID:    1001935

   Ende der Mitteilung    DGAP News-Service
---------------------------------------------------------------------------

1001935 19.03.2020

 ISIN  NL0012044747  DE000A19Y072

AXC0392 2020-03-19/15:50

Copyright APA/dpa-AFX. Alle Rechte vorbehalten. Weiterverbreitung, Wiederveröffentlichung oder dauerhafte Speicherung ohne ausdrückliche vorherige Zustimmung von APA/dpa-AFX ist nicht gestattet.